Live Breaking News & Updates on Generay Biotech Co Ltd

Industrial application of icariin and baohuoside I has been hindered by the short supply to a great extent. In this work, a novel GH78 α-l-rhamnosidase AmRha catalyzed the bioconversion of low-value epimedin C in crude Epimedium Folium flavonoids (EFs) to icariin and baohuoside I was developed. Firstly, the high-level expression of AmRha in Komagataella phaffii GS115 attained an enzyme activity of 571.04 U/mL. The purified recombinant AmRha could hydrolyze α-1,2-rhamnoside bond between two rhamnoses (α-Rha(2 → 1)α-Rha) in epimedin C to produce icariin with a molar conversion rate of 92.3%, in vitro. Furtherly, the biotransformation of epimedin C to icariin by the recombinant Komagataella phaffii GS115 cells was also investigated, which elevated the EFs concentration by fivefold. In addition, biotransformation of epimedins A-C and icariin in the raw EFs to baohuoside I was fulfilled by a collaboration of AmRha and β-glucosidase/β-xylosidas ....

United States , Dligase Takara , Takara Bio , Amrha Genbank , Bio Rad Aminex , Aldrich Trading Co Ltd , Technology Chengdu , Jiangsu Kanion Pharmaceutical Co , Vazyme Biotech Co , Generay Biotech Co Ltd , Shanghai Aladdin Biochemical Technology Co Ltd , Microbiology Laboratory Nanjing Forestry University , Shaanxi Tianneng Co Ltd , Chengdu Must Bio Technology , Epimedium Folium , Jiangsu Kanion Pharmaceutical , Vazyme Biotech , Microbiology Laboratory , Nanjing Forestry University , Minelute Gel Extraction Kit , Plasmid Miniprep Kit , Swiss Model , Fast Flow , Sangon Biotech ,